Characterization of phosphatidylserine-dependent β2-glycoprotein I macrophage interactions -: Implications for apoptotic cell clearance by phagocytes

被引:114
作者
Balasubramanian, K [1 ]
Schroit, AJ [1 ]
机构
[1] Univ Texas, MD Anderson Cancer Ctr, Dept Cell Biol, Houston, TX 77030 USA
关键词
D O I
10.1074/jbc.273.44.29272
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The binding and uptake of phosphatidylserine (PS)-expressing cells appears to involve multiple receptor-mediated systems that recognize the lipid either directly or indirectly through intermediate proteins that form a molecular bridge between the cells. Here we show that beta(2)-glycoprotein I (beta(2)GPI), a 50-kDa serum glycoprotein, binds PS-containing vesicles and serves as an intermediate for the interaction of these vesicles with macrophages. Chemical modification of lysines and cysteines abolished beta(2)GPI-dependent PS uptake by inhibiting the binding of PS to beta(2)GPI and the binding of PS.beta(2)GPI complex to macrophages, respectively, Recognition was mediated by beta(2)GPI and not by the lipid because antibodies to beta(2)GPI inhibited binding of the complex to macrophages. These results indicate that human (THP-l-derived) macrophages bind beta(2)GPI only after it is bound to its lipid ligand, Competition experiments with monosaccharides that inhibit lectin-dependent interactions, and PS.beta(2)GPI binding experiments using deglycosylated beta(2)GPI, suggested that carbohydrate residues were not required for macrophage recognition of the complex. Antibodies to putative macrophage PS receptors (CD36, CD68, and CD14) did not inhibit uptake of the complex. These data suggest that beta(2)GPI can bind cells that fail to maintain membrane lipid asymmetry and generate a specific bridging moiety that is recognized for clearance by a phagocyte receptor that is distinct from CD36, CD68, and CD14.
引用
收藏
页码:29272 / 29277
页数:6
相关论文
共 33 条
[1]   Immune clearance of phosphatidylserine-expressing cells by phagocytes -: The role of β2-glycoprotein I in macrophage recognition [J].
Balasubramanian, K ;
Chandra, J ;
Schroit, AJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (49) :31113-31117
[2]  
BORCHMAN D, 1995, CLIN EXP IMMUNOL, V102, P373
[3]   Beta(2)-glycoprotein I in thrombosis: Evidence for a role as a natural anticoagulant [J].
Brighton, TA ;
Hogg, BJ ;
Dai, YP ;
Murray, BH ;
Chong, BH ;
Chesterman, CN .
BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 (01) :185-194
[4]   BETA-2-GLYCOPROTEIN-I IS A MAJOR PROTEIN ASSOCIATED WITH VERY RAPIDLY CLEARED LIPOSOMES IN-VIVO, SUGGESTING A SIGNIFICANT ROLE IN THE IMMUNE CLEARANCE OF NON-SELF PARTICLES [J].
CHONN, A ;
SEMPLE, SC ;
CULLIS, PR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (43) :25845-25849
[5]  
COHNEN G, 1969, J LAB CLIN MED, V75, P212
[6]  
CONNOR J, 1992, J BIOL CHEM, V267, P19412
[7]   ESSENTIAL ARGINYL RESIDUES IN ESCHERICHIA-COLI ALKALINE-PHOSPHATASE [J].
DAEMEN, FJM ;
RIORDAN, JF .
BIOCHEMISTRY, 1974, 13 (14) :2865-2871
[8]   Human CD14 mediates recognition and phagocytosis of apoptotic cells [J].
Devitt, A ;
Moffatt, OD ;
Raykundalia, C ;
Capra, JD ;
Simmons, DL ;
Gregory, CD .
NATURE, 1998, 392 (6675) :505-509
[9]  
FADOK VA, 1992, J IMMUNOL, V148, P2207
[10]   RECOGNITION OF APOPTOTIC CELLS BY HUMAN MACROPHAGES - INHIBITION BY A MONOCYTE/MACROPHAGE-SPECIFIC MONOCLONAL-ANTIBODY [J].
FLORA, PK ;
GREGORY, CD .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (11) :2625-2632